Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katarina Dathe

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Frontiers in Public Health|September 9, 2020
Estimating the Beginning of Pregnancy in German Claims Data: Development of an Algorithm With a Focus on the Expected Delivery DateTania Schink, Nadine Wentzell, Katarina Dathe, et al.
Frontiers in Public Health|November 16, 2020
Corrigendum: Estimating the Beginning of Pregnancy in German Claims Data: Development of an Algorithm With a Focus on the Expected Delivery DateTania Schink, Nadine Wentzell, Katarina Dathe, et al.
Scientific Reports|December 23, 2024
Trends in use of antiseizure medication and treatment pattern during the first trimester in the German Embryotox cohortMaria Hoeltzenbein, Sofia Slimi, Anne-Katrin Fietz, et al.
European Journal of Clinical Pharmacology|January 27, 2021
Ivabradine use in pregnant women-treatment indications and pregnancy outcome: an evaluation of the German Embryotox databaseMaria Hoeltzenbein, Marie-Louise Lehmann, Evelin Beck, et al.
Scientific Reports|February 18, 2025
Author Correction: Trends in use of antiseizure medication and treatment pattern during the first trimester in the German Embryotox cohortMaria Hoeltzenbein, Sofia Slimi, Anne-Katrin Fietz, et al.
Scientific Reports|January 5, 2024
Impact of maternal first trimester treatment regimen on the outcome of valproate exposed pregnancies: an observational Embryotox cohort studyAnne-Katrin Fietz, Marlies Onken, Stephanie Padberg, et al.
Pharmacoepidemiology and Drug Safety|October 18, 2023
How to account for early overly small risk sets in the analysis of pregnancy outcome data?-Comparison of different methods for stabilizing the Aalen-Johansen estimatorRegina Stegherr, Anne-Katrin Fietz, Maria Hoeltzenbein, et al.
BMC Pregnancy and Childbirth|August 26, 2022
Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohortKatarina Dathe, Johanna Frank, Stephanie Padberg, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 20, 2021
First trimester naproxen exposure and outcome of pregnancy - A German case seriesStefanie Hultzsch, Wolfgang Paulus, Stephanie Padberg, et al.
European Journal of Pediatrics|July 22, 2025
Does extended follow-up period after birth improve precision of diagnosis of congenital anomalies? An observational study based on the Berlin Embryotox projectCorinna Weber-Schoendorfer, Nadia Maaß, Lukas Lohse, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Frontiers in Public Health|September 9, 2020
Estimating the Beginning of Pregnancy in German Claims Data: Development of an Algorithm With a Focus on the Expected Delivery DateTania Schink, Nadine Wentzell, Katarina Dathe, et al.
Frontiers in Public Health|November 16, 2020
Corrigendum: Estimating the Beginning of Pregnancy in German Claims Data: Development of an Algorithm With a Focus on the Expected Delivery DateTania Schink, Nadine Wentzell, Katarina Dathe, et al.
Scientific Reports|December 23, 2024
Trends in use of antiseizure medication and treatment pattern during the first trimester in the German Embryotox cohortMaria Hoeltzenbein, Sofia Slimi, Anne-Katrin Fietz, et al.
European Journal of Clinical Pharmacology|January 27, 2021
Ivabradine use in pregnant women-treatment indications and pregnancy outcome: an evaluation of the German Embryotox databaseMaria Hoeltzenbein, Marie-Louise Lehmann, Evelin Beck, et al.
Scientific Reports|February 18, 2025
Author Correction: Trends in use of antiseizure medication and treatment pattern during the first trimester in the German Embryotox cohortMaria Hoeltzenbein, Sofia Slimi, Anne-Katrin Fietz, et al.
Scientific Reports|January 5, 2024
Impact of maternal first trimester treatment regimen on the outcome of valproate exposed pregnancies: an observational Embryotox cohort studyAnne-Katrin Fietz, Marlies Onken, Stephanie Padberg, et al.
Pharmacoepidemiology and Drug Safety|October 18, 2023
How to account for early overly small risk sets in the analysis of pregnancy outcome data?-Comparison of different methods for stabilizing the Aalen-Johansen estimatorRegina Stegherr, Anne-Katrin Fietz, Maria Hoeltzenbein, et al.
BMC Pregnancy and Childbirth|August 26, 2022
Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohortKatarina Dathe, Johanna Frank, Stephanie Padberg, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 20, 2021
First trimester naproxen exposure and outcome of pregnancy - A German case seriesStefanie Hultzsch, Wolfgang Paulus, Stephanie Padberg, et al.
European Journal of Pediatrics|July 22, 2025
Does extended follow-up period after birth improve precision of diagnosis of congenital anomalies? An observational study based on the Berlin Embryotox projectCorinna Weber-Schoendorfer, Nadia Maaß, Lukas Lohse, et al.
Pageof 5